Clinical trial

Safety and Performance Study of the Moderato System

NCT02282033

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-03-01

PhaseNA

Study timeline

Study start (actual)2013-03-01Date precision: month

Registry last updated2018-02-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension Resistant to Conventional Therapyunresolved

Bradycardiaunresolved

Atrioventricular Blockunresolved

Interventions

The Moderato SystemDEVICE

Sponsors & collaborators

BackBeat Medical Inclead sponsor

Massachusetts General Hospitalcollaborator

MLM Medical Labs GmbHcollaborator

nabios GmbHcollaborator

Mapped research locations

SantiagoChile2 BudapestHungary1 PragueCzechia1 ViennaAustria1 AmsterdamNetherlands1 UtrechtNetherlands1 RigaLatvia1 LinzAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02282033 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.